Back to ABT overview
#
ABT Abbott Laboratories
PE ratio, current and historical analysis

## ABT PE ratio history

### Abbott Laboratories PE ratio by year

## ABT average PE ratio chart

## ABT PE vs peers

## Frequently asked questions

###
What is Abbott Laboratories's PE ratio?

###
What is the 3-year average PE ratio for Abbott Laboratories (ABT)?

###
What is the 5-year average PE ratio for Abbott Laboratories (ABT)?

###
What is the highest PE ratio for ABT?

###
How does the current PE ratio for ABT compare to its historical average?

###
How is ABT's PE ratio calculated (Abbott Laboratories PE ratio formula)?

The current PE ratio for Abbott Laboratories stock as of Jun 14, 2024 is 32.1. This is calculated based on the current EPS of $3.23 and the stock price of $103.68 per share. The P/E ratio has a decrease of 7% from the past four quarters average of 34.6.

How has ABT's PE ratio performed in the past

The average historical PE ratio of Abbott Laboratories for the last ten years is 49.81. The current PE ratio of 32.1 is 36% below the historical average. Over the past ten years, ABT's PE ratio was at its highest in the Mar 2018 quarter at 230.46, when the stock price was $59.92 and the EPS was $0.26. The lowest value was in the Sep 2015 quarter, when it reached 13.27 with a price of $40.22 and an EPS of $3.03.

Average

49.81

Median

36.21

Minimum

13.27

Maximum

230.46

Maximum annual increase: 417.3% in 2017

Maximum annual decrease: -74.46% in 2018

Year | PE ratio | Change |
---|---|---|

2023 | 33.56 | 20.42% |

2022 | 27.87 | -21.38% |

2021 | 35.45 | -18.41% |

2020 | 43.45 | 3.55% |

2019 | 41.96 | -22.27% |

2018 | 53.98 | -74.46% |

2017 | 211.37 | 417.3% |

2016 | 40.86 | 167.41% |

2015 | 15.28 | -49.08% |

2014 | 30.01 | 28.41% |

What is the average PE ratio of ABT for the past years

ABT's current P/E ratio is above the 3-year historical average, but it is below the 5 and 10-year averages.

3-year avg

30.45

5-year avg

36.65

10-year avg

49.81

15-year avg

38.81

What is ABT's PE ratio compared to its peers

Compared to its peers AZN and TMO, ABT's PE ratio stands lower, however it is higher than JNJ's and NVS's. Abbott Laboratories's current PE ratio of 32.1 is comparable to the average of its peer group, which is 32.22.

Stock name | PE ratio | Market cap |
---|---|---|

JNJ Johnson & Johnson | 9.54 | $350.27B |

NVS Novartis AG | 14.27 | $215.71B |

MDT Medtronic plc | 25.73 | $107.61B |

ABT Abbott Laboratories | 32.1 | $180.37B |

TMO Thermo Fisher Scientific Inc | 36.55 | $218.36B |

HOLX Hologic Inc | 36.63 | $16.75B |

AZN Astrazeneca plc | 38.82 | $246.75B |

BSX Boston Scientific Corp | 63.97 | $112.85B |

PFE Pfizer Inc | N/A | $156B |

BMY Bristol Myers Squibb Co | N/A | $83.52B |

As of Jun 14, 2024, ABT stock has a price to earnings ratio of 32.1.

The average PE ratio for ABT stock over the past 3 years is 30.45.

The average PE ratio for ABT stock over the past 5 years is 36.65.

Over the last ten years, the quarterly PE ratio reached a historic high of 230.46 in the Mar 2018 quarter.

The current price to earnings ratio of ABT is 36% lower than the 10-year historical average.

The PE ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Jun 14, 2024), Abbott Laboratories's stock price is $103.68. The earnings per share for the trailing twelve months (TTM) ending Mar 2024 is $3.23. Therefore, Abbott Laboratories's P/E ratio for today is 32.1. `PE RATIO(32.1) = STOCK PRICE($103.68) / TTM EPS($3.23)`

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.